Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
University of Cambridge Develops AI-Designed Vaccine Targeting Multiple Coronaviruses

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. tech

University of Cambridge Develops AI-Designed Vaccine Targeting Multiple Coronaviruses

Reviewed byAshwin Alsi· Technology Editor· Edited byOjas Kale
Analysed 10 Jun 2026·2 sources analysed·India·tech
University of Cambridge Develops AI-Designed Vaccine Targeting Multiple CoronavirusesPreviousNext

Researchers at the University of Cambridge have developed the world's first vaccine designed entirely by artificial intelligence (AI), targeting the sarbecovirus family, which includes SARS, COVID-19, and related animal coronaviruses. This DNA-based vaccine aims to provide broad protection against current and potential future viruses by focusing on stable viral features identified through AI analysis. It offers advantages such as needle-free administration via a high-pressure liquid stream and improved stability, facilitating easier storage and distribution, especially in low-resource settings. The vaccine has been tested in humans for the first time, marking a significant step toward pandemic preparedness.

TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (75/100). Lens Score 28/100 — low public interest.

Outlets analysed (first-hand measurement by TBN's Bias Engine):

  • businessstandard— balanced framing, positive sentiment
  • news18— balanced framing, positive sentiment
Political Bias
0%100%0%
Sentiment
75%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 10 Jun 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 0%● Center 100%● Right 0%

The articles present a scientific and technological development without evident political framing. Coverage focuses on the innovation and potential public health benefits, reflecting perspectives from researchers and experts. There is no partisan commentary or political debate, and the narrative centers on the vaccine's design, testing, and implications for future pandemic prevention.

Sentiment — Positive (75/100)

The tone across the articles is generally positive and optimistic, emphasizing the vaccine's innovative AI design and potential to address challenges posed by viral mutations. While cautious about the vaccine being newly tested in humans, the coverage highlights its advantages and significance, conveying hope for improved pandemic response without overstating outcomes.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

← Previous
Gartner Forecasts 26% Rise in Global Data Center Electricity Demand in 2026 Driven by AI
Next →
Anthropic's Claude AI Sparks Online Amusement and Raises Consciousness Concerns
SourceTheir headlineBiasSentiment
businessstandardWorld's first AI-designed vaccine to battle all animal-to-human virusesCenterPositive
news18Worlds first AI-designed vaccine explainedCenterPositive

Coverage timeline

news18 broke this story on 10 Jun, 06:03 am. Other outlets followed.

  1. 1
    news1810 Jun, 06:03 am
    Worlds first AI-designed vaccine explained
  2. 2
    businessstandard10 Jun, 04:40 pm
    World's first AI-designed vaccine to battle all animal-to-human viruses

Lens Score breakdown

28/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Story context

Category
Tech
Location
India
Sources analysed
2
Last analysed
10 Jun 2026
Key entities
Artificial intelligenceVaccineVirusCoronavirusUniversity of CambridgePandemicDNA vaccineCOVID-19 vaccineMutationGeneticsImmune systemBat